Sakai N - Search Results

1

Fasting serum apolipoprotein B-48 can be a marker of postprandial hyperlipidemia.

Masuda D, Sakai N, Sugimoto T, Kitazume-Taneike R, Yamashita T, Kawase R, Nakaoka H, Inagaki M, Nakatani K, Yuasa-Kawase M, Tsubakio-Yamamoto K, Ohama T, Nakagawa-Toyama Y, Nishida M, Ishigami M, Masuda Y, Matsuyama A, Komuro I, Yamashita S. Masuda D, et al. Among authors: sakai n. J Atheroscler Thromb. 2011;18(12):1062-70. doi: 10.5551/jat.10470. Epub 2011 Sep 24. J Atheroscler Thromb. 2011. PMID: 21946533 Free article.

2

Atorvastatin markedly improves type III hyperlipoproteinemia in association with reduction of both exogenous and endogenous apolipoprotein B-containing lipoproteins.

Ishigami M, Yamashita S, Sakai N, Hirano K, Hiraoka H, Nakamura T, Matsuzawa Y. Ishigami M, et al. Among authors: sakai n. Atherosclerosis. 2003 Jun;168(2):359-66. doi: 10.1016/s0021-9150(03)00136-9. Atherosclerosis. 2003. PMID: 12801620

3

Correlation of fasting serum apolipoprotein B-48 with coronary artery disease prevalence.

Masuda D, Sugimoto T, Tsujii K, Inagaki M, Nakatani K, Yuasa-Kawase M, Tsubakio-Yamamoto K, Ohama T, Nishida M, Ishigami M, Kawamoto T, Matsuyama A, Sakai N, Komuro I, Yamashita S. Masuda D, et al. Among authors: sakai n. Eur J Clin Invest. 2012 Sep;42(9):992-9. doi: 10.1111/j.1365-2362.2012.02687.x. Epub 2012 May 15. Eur J Clin Invest. 2012. PMID: 22587365

4

Measurement of fasting serum apoB-48 levels in normolipidemic and hyperlipidemic subjects by ELISA.

Sakai N, Uchida Y, Ohashi K, Hibuse T, Saika Y, Tomari Y, Kihara S, Hiraoka H, Nakamura T, Ito S, Yamashita S, Matsuzawa Y. Sakai N, et al. J Lipid Res. 2003 Jun;44(6):1256-62. doi: 10.1194/jlr.M300090-JLR200. Epub 2003 Apr 1. J Lipid Res. 2003. PMID: 12671037 Free article.

5

Human scavenger receptor class B type I is expressed with cell-specific fashion in both initial and terminal site of reverse cholesterol transport.

Nakagawa-Toyama Y, Hirano K, Tsujii K, Nishida M, Miyagawa J, Sakai N, Yamashita S. Nakagawa-Toyama Y, et al. Among authors: sakai n. Atherosclerosis. 2005 Nov;183(1):75-83. doi: 10.1016/j.atherosclerosis.2005.02.035. Epub 2005 Jun 20. Atherosclerosis. 2005. PMID: 15970294

6

Identification of unique lipoprotein subclasses for visceral obesity by component analysis of cholesterol profile in high-performance liquid chromatography.

Okazaki M, Usui S, Ishigami M, Sakai N, Nakamura T, Matsuzawa Y, Yamashita S. Okazaki M, et al. Among authors: sakai n. Arterioscler Thromb Vasc Biol. 2005 Mar;25(3):578-84. doi: 10.1161/01.ATV.0000155017.60171.88. Epub 2005 Jan 6. Arterioscler Thromb Vasc Biol. 2005. PMID: 15637308

7

Familial massive tendon xanthomatosis with decreased high-density lipoprotein-mediated cholesterol efflux.

Matsuura F, Hirano K, Koseki M, Ohama T, Matsuyama A, Tsujii K, Komuro R, Nishida M, Sakai N, Hiraoka H, Nakamura T, Yamashita S. Matsuura F, et al. Among authors: sakai n. Metabolism. 2005 Aug;54(8):1095-101. doi: 10.1016/j.metabol.2005.03.014. Metabolism. 2005. PMID: 16092061

8

Dominant expression of ATP-binding cassette transporter-1 on basolateral surface of Caco-2 cells stimulated by LXR/RXR ligands.

Ohama T, Hirano K, Zhang Z, Aoki R, Tsujii K, Nakagawa-Toyama Y, Tsukamoto K, Ikegami C, Matsuyama A, Ishigami M, Sakai N, Hiraoka H, Ueda K, Yamashita S, Matsuzawa Y. Ohama T, et al. Among authors: sakai n. Biochem Biophys Res Commun. 2002 Aug 23;296(3):625-30. doi: 10.1016/s0006-291x(02)00853-7. Biochem Biophys Res Commun. 2002. PMID: 12176027

9

Retarded intracellular lipid transport associated with reduced expression of Cdc42, a member of Rho-GTPases, in human aged skin fibroblasts: a possible function of Cdc42 in mediating intracellular lipid transport.

Tsukamoto K, Hirano K, Yamashita S, Sakai N, Ikegami C, Zhang Z, Matsuura F, Hiraoka H, Matsuyama A, Ishigami M, Matsuzawa Y. Tsukamoto K, et al. Among authors: sakai n. Arterioscler Thromb Vasc Biol. 2002 Nov 1;22(11):1899-904. doi: 10.1161/01.atv.0000036080.42391.33. Arterioscler Thromb Vasc Biol. 2002. PMID: 12426222

10

Prevalence and phenotypic spectrum of cholesteryl ester transfer protein gene mutations in Japanese hyperalphalipoproteinemia.

Maruyama T, Sakai N, Ishigami M, Hirano K, Arai T, Okada S, Okuda E, Ohya A, Nakajima N, Kadowaki K, Fushimi E, Yamashita S, Matsuzawa Y. Maruyama T, et al. Among authors: sakai n. Atherosclerosis. 2003 Jan;166(1):177-85. doi: 10.1016/s0021-9150(02)00327-1. Atherosclerosis. 2003. PMID: 12482565

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,641 results

Search Page

Filters